Ubs Group Ag Organogenesis Holdings Inc. Transaction History

Ubs Group Ag

$528 Billion
Q1 2025

A detailed history of Ubs Group Ag transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Ubs Group Ag holds 345,658 shares of ORGO stock, worth $947,102. This represents 0.0% of its overall portfolio holdings.

Number of Shares

345,658

Previous 56,896 507.53%

Holding current value

$947,102

Previous $182,000 720.33%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	BUY	$2.89 - $6.21 $834,522 - $1.79 Million	288,762 Added 507.53%	345,658 $1.49 Million
Q4 2024 Feb 14, 2025	SELL	$2.77 - $4.43 $5,382 - $8,607	-1,943 Reduced 3.3%	56,896 $182,000
Q3 2024 Nov 14, 2024	BUY	$2.42 - $3.24 $28,548 - $38,222	11,797 Added 25.08%	58,839 $168,000
Q2 2024 Aug 13, 2024	SELL	$2.28 - $3.03 $65,910 - $87,591	-28,908 Reduced 38.06%	47,042 $131,000
Q1 2024 May 13, 2024	BUY	$2.61 - $4.49 $4,209 - $7,242	1,613 Added 2.17%	75,950 $215,000
Q4 2023 Feb 09, 2024	BUY	$1.97 - $4.21 $51,791 - $110,680	26,290 Added 54.72%	74,337 $304,000
Q3 2023 Nov 09, 2023	BUY	$2.34 - $4.43 $107,747 - $203,983	46,046 Added 2301.15%	48,047 $152,000
Q2 2023 Aug 11, 2023	SELL	$1.9 - $4.3 $17,352 - $39,271	-9,133 Reduced 82.03%	2,001 $6,000
Q1 2023 May 12, 2023	BUY	$1.89 - $2.93 $9,708 - $15,051	5,137 Added 85.66%	11,134 $23,000
Q4 2022 Feb 08, 2023	BUY	$2.48 - $3.43 $14,870 - $20,566	5,996 Added 599600.0%	5,997 $16,000
Q1 2022 May 16, 2022	SELL	$6.47 - $9.57 $3,810 - $5,636	-589 Reduced 99.83%	1 $0
Q4 2021 Feb 14, 2022	SELL	$9.02 - $13.5 $1.62 Million - $2.42 Million	-179,118 Reduced 99.67%	590 $5,000
Q3 2021 Nov 15, 2021	BUY	$13.71 - $17.18 $540,215 - $676,943	39,403 Added 28.08%	179,708 $2.56 Million
Q2 2021 Aug 13, 2021	BUY	$14.92 - $23.23 $2.06 Million - $3.21 Million	137,988 Added 5955.46%	140,305 $2.33 Million
Q1 2021 May 12, 2021	SELL	$7.33 - $21.06 $23,492 - $67,497	-3,205 Reduced 58.04%	2,317 $42,000
Q4 2020 Feb 11, 2021	BUY	$3.63 - $7.53 $15,892 - $32,966	4,378 Added 382.69%	5,522 $42,000
Q3 2020 Nov 12, 2020	SELL	$3.29 - $4.58 $26,349 - $36,681	-8,009 Reduced 87.5%	1,144 $4,000
Q2 2020 Jul 31, 2020	BUY	$2.86 - $4.61 $6,886 - $11,100	2,408 Added 35.7%	9,153 $35,000
Q1 2020 May 01, 2020	SELL	$2.92 - $5.31 $19,899 - $36,187	-6,815 Reduced 50.26%	6,745 $22,000
Q4 2019 Feb 14, 2020	BUY	$4.7 - $8.11 $14,795 - $25,530	3,148 Added 30.23%	13,560 $65,000
Q3 2019 Nov 14, 2019	BUY	$3.57 - $8.09 $20,470 - $46,388	5,734 Added 122.57%	10,412 $68,000
Q2 2019 Aug 14, 2019	BUY	$6.58 - $8.69 $30,781 - $40,651	4,678 New	4,678 $36,000

Others Institutions Holding ORGO

# of Institutions

142

Shares Held

64.5M

Call Options Held

15.3K

Put Options Held

925

View Full List

About Organogenesis Holdings Inc.

Ticker ORGO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 130,888,000
Market Cap $359M
Description
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...

More about ORGO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account